These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 218497)

  • 1. Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.
    Henderson EE; Long WK; Ribecky R
    Antimicrob Agents Chemother; 1979 Jan; 15(1):101-10. PubMed ID: 218497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.
    Manor D; Margalith M
    Cancer Biochem Biophys; 1979; 3(4):157-62. PubMed ID: 233303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.
    Benz WC; Siegel PJ; Baer J
    J Virol; 1978 Sep; 27(3):475-82. PubMed ID: 212577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of n-butyrate on transformation of human lymphocytes by Epstein-Barr virus.
    Roubalová K; Roubal J
    Intervirology; 1985; 23(1):51-4. PubMed ID: 2982760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
    Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
    Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of S-adenosylhomocysteine and analogs on Epstein-Barr virus-induced transformation, expression of the Epstein-Barr virus capsid antigen, and methylation of Epstein-Barr virus DNA.
    Long WK; Fronko GE; Lindemeyer RG; Wu B; Henderson EE
    J Virol; 1987 Jan; 61(1):221-4. PubMed ID: 3023700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.
    Robinson J
    J Virol; 1975 May; 15(5):1065-72. PubMed ID: 167182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue of transforming Epstein-Barr virus (EBV) from EBV-genome-positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA.
    Stoerker J; Glaser R
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1726-9. PubMed ID: 6300871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid.
    Lemon SM; Hutt LM; Pagano JS
    J Virol; 1978 Jan; 25(1):138-45. PubMed ID: 202732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
    Margalith M; Manor D; Usieli V; Goldblum N
    Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiobiological inactivation of Epstein-Barr virus.
    Henderson E; Heston L; Grogan E; Miller G
    J Virol; 1978 Jan; 25(1):51-9. PubMed ID: 202757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains.
    Desgranges C; Lavoué MF; Patet J; de-Thé G
    Biomedicine; 1979 Jun; 30(2):102-8. PubMed ID: 224964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
    Margalith M; Manor D; Cohen T
    Cancer Biochem Biophys; 1983; 6(3):189-96. PubMed ID: 6303555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers.
    Lvovsky E; Levine PH; Fuccillo D; Ablashi DV; Bengali ZH; Armstrong GR; Levy HB
    J Natl Cancer Inst; 1981 Jun; 66(6):1013-9. PubMed ID: 6165852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuramide inhibits Epstein-Barr virus-induced transformation activity and proliferation of transformed B lymphocytes.
    Venanzoni MC; Angeloni A; Di Muzio M; Faggioni A; Frati L
    Antiviral Res; 1997 Feb; 33(3):177-85. PubMed ID: 9037374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferons on the transformation of non-T blood mononuclear leukocytes by Epstein--Barr virus.
    Chang RS
    J Interferon Res; 1984; 4(2):173-7. PubMed ID: 6086777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate.
    Rickinson AB; Epstein MA
    J Gen Virol; 1978 Aug; 40(2):409-20. PubMed ID: 211188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.